Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lunghi, Francesca
TFR-PRO, NCT04621851: Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation	Recruiting	N/A	3000	Europe, Canada		University of Milano Bicocca	Chronic Myeloid Leukemia	09/21	09/23
MPN-COVID, NCT04385160: Myeloproliferative Neoplasms (MPN) and COVID-19	Recruiting	N/A	552	Europe, US, RoW		Fondazione per la Ricerca Ospedale Maggiore, European Leukemia Net	Myeloproliferative Neoplasm, COVID	02/22	08/22
NCT06506084: Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)	Recruiting	N/A	319	Europe	Ropeginterferon alfa-2b, Besremi	FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS	Polycythemia Vera	09/26	12/26
ERNEST-3, NCT06533813: Clinical Epidemiology in Contemporary Patients With Myelofibrosis.	Recruiting	N/A	617	Europe, RoW		FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, GlaxoSmithKline	Myelofibrosis	12/25	12/28

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lunghi, Francesca
TFR-PRO, NCT04621851: Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation	Recruiting	N/A	3000	Europe, Canada		University of Milano Bicocca	Chronic Myeloid Leukemia	09/21	09/23
MPN-COVID, NCT04385160: Myeloproliferative Neoplasms (MPN) and COVID-19	Recruiting	N/A	552	Europe, US, RoW		Fondazione per la Ricerca Ospedale Maggiore, European Leukemia Net	Myeloproliferative Neoplasm, COVID	02/22	08/22
NCT06506084: Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)	Recruiting	N/A	319	Europe	Ropeginterferon alfa-2b, Besremi	FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS	Polycythemia Vera	09/26	12/26
ERNEST-3, NCT06533813: Clinical Epidemiology in Contemporary Patients With Myelofibrosis.	Recruiting	N/A	617	Europe, RoW		FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, GlaxoSmithKline	Myelofibrosis	12/25	12/28